跳转至内容
Merck
所有图片(1)

主要文件

查看所有文档

H6132

Sigma-Aldrich

DL -3-羟基-3-甲基戊二酰辅酶 A 钠盐 水合物

≥90% (HPLC)

别名:

[=β-hydroxy-β-mathylglutaryl-CoA]β-羟-β-甲基戊二酸单酰辅酶A

登录查看公司和协议定价
所有图片(1)

About This Item

经验公式（希尔记法）:
C27H42N7Na2O20P3S · xH2O
CAS号:
103476-21-7
分子量:
955.62 (anhydrous basis)
分類程式碼代碼:
41106305
PubChem物質ID:
24895729
NACRES:
NA.51

品質等級

200

化驗

≥90% (HPLC)

儲存溫度

−20°C

SMILES 字串

O.[Na+].[Na+].CC(O)(CC(O)=O)CC(=O)SCCNC(=O)CCNC(=O)[C@@H](O)C(C)(C)COP(O)(=O)OP(O)(=O)OC[C@H]1O[C@H]([C@H](O)[C@@H]1OP([O-])([O-])=O)n2cnc3c(N)ncnc23

InChI

1S/C27H44N7O20P3S.2Na.H2O/c1-26(2,21(40)24(41)30-5-4-15(35)29-6-7-58-17(38)9-27(3,42)8-16(36)37)11-51-57(48,49)54-56(46,47)50-10-14-20(53-55(43,44)45)19(39)25(52-14)34-13-33-18-22(28)31-12-32-23(18)34;;;/h12-14,19-21,25,39-40,42H,4-11H2,1-3H3,(H,29,35)(H,30,41)(H,36,37)(H,46,47)(H,48,49)(H2,28,31,32)(H2,43,44,45);;;1H2/q;2*+1;/p-2/t14-,19-,20-,21-,25-,27?;;;/m1.../s1

InChI 密鑰

QGWMCHPRNDWWMT-UAUHQYJPSA-L

相关类别

一般說明

DL-3-羟基-3-甲戊二酰辅酶A(HMG-CoA)在HMG-CoA合酶作用下由乙酰CoA和乙酰乙酰CoA缩合而成。

應用

DL-3-羟基-3-甲戊二酰辅酶A钠盐水合物已用于在药物治疗中研究其对mTORC1调控的影响。它还用于比较两种反应性酰基辅酶A（如HMG-CoA和戊二酰-CoA）的酰化蛋白组。

生化／生理作用

DL-3-羟基-3-甲戊二酰辅酶A(HMG-CoA)可作为底物用于研究3-羟基-3-甲戊二酰辅酶A(HMG-CoA)还原酶的特异性和动力学。 羟甲基戊二酰辅酶A(HMG-CoA)是萜类和酮类生物合成的关键中间体。它的代谢是他汀类药物的靶点，通过其控制胆固醇水平。
DL-3-羟基-3-甲戊二酰辅酶A(HMG-CoA)可作为胆固醇合成的前体，抑制羟甲基戊二酰辅酶A(HMG-CoA)会降低胆固醇的生成。它在血液中可转化生成β-羟基丁酸。羟甲基戊二酰辅酶A(HMG-CoA)是胆固醇生物合成的调节酶，可偶联LDL受体调节胆固醇合成，受到抑制后会降低胆固醇的生成。

儲存類別代碼

11 - Combustible Solids

水污染物質分類（WGK）

WGK 3

閃點（°F）

Not applicable

閃點（°C）

Not applicable

個人防護裝備

Eyeshields, Gloves, type N95 (US)

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ （Lot或Batch）字后找到。

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Yoshiko Mizuno et al.
Journal of atherosclerosis and thrombosis, 18(5), 351-358 (2011-03-24)
Atherosclerosis is a progressive disease causally associated with multiple cardiovascular risk factors, including dyslipidemia. Without effective intervention, atherosclerosis becomes evidenced clinically as coronary artery and cerebrovascular disease, both of which remain the leading causes of death worldwide. Multiple lines of
Anti-Inflammatory Treatment
Coronary Artery Disease, 237-271 (2018)
Leucine Signals to mTORC1 via Its Metabolite Acetyl-Coenzyme A
Son SM, et al.
Cell Metabolism, 29(1), 192-201 (2019)
Sarah Statt et al.
American journal of respiratory cell and molecular biology, 53(5), 689-702 (2015-04-16)
Statins are widely used to prevent cardiovascular disease. In addition to their inhibitory effects on cholesterol synthesis, statins have beneficial effects in patients with sepsis and pneumonia, although molecular mechanisms have mostly remained unclear. Using human airway epithelial cells as
Helle Keinicke et al.
Endocrine connections, 9(8), 755-768 (2020-07-21)
The prevalence of non-alcoholic fatty liver disease (NAFLD) has increased dramatically worldwide and, subsequently, also the risk of developing non-alcoholic steatohepatitis (NASH), hepatic fibrosis, cirrhosis and cancer. Today, weight loss is the only available treatment, but administration of fibroblast growth
查看所有相关文献

商品

Cholesterol Biosynthesis

Biosynthesis of cholesterol generally takes place in the endoplasmic reticulum of hepatic cells and begins with acetyl- CoA, which is mainly derived from an oxidation reaction in the mitochondria. Acetyl-CoA and acetoacetyl-CoA are converted to 3-hydroxy- 3-methylglutaryl-CoA (HMG-CoA) by HMG-CoA synthase.

Dietary Terpenes

Terpenes comprise the largest and most diverse class of secondary metabolites; approximately 55,000 compounds have been identified to date.

Dietary Terpenes

Terpenes comprise the largest and most diverse class of secondary metabolites; approximately 55,000 compounds have been identified to date.

Antilipemic Agents

Randomized controlled clinical studies have suggested 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors (statins) are effective in both primary and secondary prevention of cardiovascular disease (CVD) events.

查看所有结果

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门